These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 7982172)
1. High prevalence of p53 protein overexpression in patients with esophageal cancer in Linxian, China and its relationship to progression and prognosis. Wang DY; Xiang YY; Tanaka M; Li XR; Li JL; Shen Q; Sugimura H; Kino I Cancer; 1994 Dec; 74(12):3089-96. PubMed ID: 7982172 [TBL] [Abstract][Full Text] [Related]
2. Mutational spectra of p53 in geographically localized esophageal squamous cell carcinoma groups in China. Cao W; Chen X; Dai H; Wang H; Shen B; Chu D; McAfee T; Zhang ZF Cancer; 2004 Aug; 101(4):834-44. PubMed ID: 15305417 [TBL] [Abstract][Full Text] [Related]
3. p53 expression and p21 expression are mutually exclusive in esophageal squamous cell carcinoma. Hamada M; Naomoto Y; Shirakawa Y; Yamatsuji T; Noma K; Motoki T; Nobuhisa T; Okawa T; Haisa M; Gunduz M; Matsuoka J; Tanaka N Oncol Rep; 2004 Jan; 11(1):57-63. PubMed ID: 14654903 [TBL] [Abstract][Full Text] [Related]
4. Clinicopathologic significance of the expression of mutated p53 protein and the proliferative activity of cancer cells in patients with esophageal squamous cell carcinoma. Ikeguchi M; Saito H; Katano K; Tsujitani S; Maeta M; Kaibara N J Am Coll Surg; 1997 Oct; 185(4):398-403. PubMed ID: 9328389 [TBL] [Abstract][Full Text] [Related]
5. Histopathologic changes seen in esophagectomy specimens from the high-risk region of Linxian, China: potential clues to an etiologic exposure? Roth MJ; Guo-Qing W; Lewin KJ; Ning L; Dawsey SM; Wesley MN; Giffen C; Yong-Qiang X; Maher MM; Taylor PR Hum Pathol; 1998 Nov; 29(11):1294-8. PubMed ID: 9824110 [TBL] [Abstract][Full Text] [Related]
6. Prognostic value of cyclin B1 in patients with esophageal squamous cell carcinoma. Takeno S; Noguchi T; Kikuchi R; Uchida Y; Yokoyama S; Müller W Cancer; 2002 Jun; 94(11):2874-81. PubMed ID: 12115375 [TBL] [Abstract][Full Text] [Related]
7. Mutation and expression of the metastasis suppressor gene KAI1 in esophageal squamous cell carcinoma. Miyazaki T; Kato H; Shitara Y; Yoshikawa M; Tajima K; Masuda N; Shouji H; Tsukada K; Nakajima T; Kuwano H Cancer; 2000 Sep; 89(5):955-62. PubMed ID: 10964324 [TBL] [Abstract][Full Text] [Related]
8. [Expression of Fas, Fas ligand, Fas-associated death domain protein, caspase 8 and mutant P53 protein in esophageal squamous cell carcinoma]. Xue LY; Ren LQ; Luo W; Guan XJ; Zou SM; Zheng S; Bi R; Xie YQ; He ZG; Lü N Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(3):150-4. PubMed ID: 17425843 [TBL] [Abstract][Full Text] [Related]
11. Prognostic values of apoptosis-stimulating P53-binding protein 1 and 2 and their relationships with clinical characteristics of esophageal squamous cell carcinoma patients: a retrospective study. Xie XF; Yang Q; Chi J; Yang XZ; Wang HY; Xu GL Chin J Cancer; 2017 Jan; 36(1):15. PubMed ID: 28103919 [TBL] [Abstract][Full Text] [Related]
13. Increased expression of high-mobility group A2: A novel independent indicator of poor prognosis in patients with esophageal squamous cell carcinoma. Wei R; Shang Z; Leng J; Cui L J Cancer Res Ther; 2016; 12(4):1291-1297. PubMed ID: 28169242 [TBL] [Abstract][Full Text] [Related]
14. [Effect of miRNA-106a expression on the prognosis of patients with esophageal squamous cell carcinoma]. Yuan JM; Mao WM; Luo J; Peng BF; Zheng ZG; Ling ZQ Zhonghua Zhong Liu Za Zhi; 2013 Aug; 35(8):590-4. PubMed ID: 24314216 [TBL] [Abstract][Full Text] [Related]
15. Alterations of p53 and PCNA in cancer and adjacent tissues from concurrent carcinomas of the esophagus and gastric cardia in the same patient in Linzhou, a high incidence area for esophageal cancer in northern China. Chen H; Wang LD; Guo M; Gao SG; Guo HQ; Fan ZM; Li JL World J Gastroenterol; 2003 Jan; 9(1):16-21. PubMed ID: 12508343 [TBL] [Abstract][Full Text] [Related]
16. p53 is an independent prognostic factor in operable esophageal squamous cell carcinoma: a large-scale study with a long follow-up. Xu XL; Zheng WH; Tao KY; Li XX; Xu WZ; Wang Y; Zhu SM; Mao WM Med Oncol; 2014 Nov; 31(11):257. PubMed ID: 25270283 [TBL] [Abstract][Full Text] [Related]
17. Aberrant expression of EZH2 is associated with a poor outcome and P53 alteration in squamous cell carcinoma of the esophagus. Yamada A; Fujii S; Daiko H; Nishimura M; Chiba T; Ochiai A Int J Oncol; 2011 Feb; 38(2):345-53. PubMed ID: 21165554 [TBL] [Abstract][Full Text] [Related]
18. p53 protein expression and prognosis in squamous cell carcinoma of the esophagus. Sarbia M; Porschen R; Borchard F; Horstmann O; Willers R; Gabbert HE Cancer; 1994 Oct; 74(8):2218-23. PubMed ID: 7922972 [TBL] [Abstract][Full Text] [Related]
19. [Expression of p53 and vascular endothelial growth factor in esophageal squamous cell carcinoma and their clinical significance]. Liu DB; Chen KN; Cao XZ; Wang T Ai Zheng; 2002 Sep; 21(9):989-93. PubMed ID: 12508548 [TBL] [Abstract][Full Text] [Related]
20. Cancer stem cell marker ALDH1 expression is associated with lymph node metastasis and poor survival in esophageal squamous cell carcinoma: a study from high incidence area of northern China. Wang Y; Zhe H; Gao P; Zhang N; Li G; Qin J Dis Esophagus; 2012 Aug; 25(6):560-5. PubMed ID: 22098156 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]